Abstract. The T cell receptor (TCR) consists of the Tiot[3 heterodimer and the associated CD378E and ge chains. The structural relationships between the subunits of the TCR complex are still not fully known. In this study we examined the role of the extracellular (EC), transmembrane (TM), and cytoplasmic (CY) domain of CD37 in assembly and cell surface expression of the complete TCR in human T cells. A computer model indicated that the EC domain of CD37 folds as an Ig domain. Based on this model and on alignment studies, two potential interaction sites were predicted in the EC domain of CD3~/. Site-directed mutagenesis demonstrated that these sites play a crucial role in TCR assembly probably by binding to CD3e. Mutagenesis of N-linked glycosylation sites showed that glycosylation of CD3~ is not required for TCR assembly and expression. In contrast, treatment of T cells with tunicamycin suggested that N-linked glycosylation of CD38 is required for TCR assembly. Site-directed mutagenesis of the acidic amino acid in the TM domain of CD3~/demonstrated that this residue is involved in TCR assembly probably by binding to Ti13. Deletion of the entire CY domain of CD3~/did not prevent assembly and expression of the TCR. In conclusion, this study demonstrated that specific TCR interaction sites exist in both the EC and TM domain of CD3% Furthermore, the study indicated that, in contrast to CD3q¢, glycosylation of CD38 is required for TCR assembly and expression. T HE T cell receptor (TCR) 1 consists of the disulfide linked Tiot13 heterodimer and the non-covalently associated CD3~/8~ and 42 chains. The function of the Tia13 dimer is to recognize antigen presented on major histocompatibility complex encoded class I or class II molecules on the surface of antigen presenting cells (15, 49), whereas the major role of the CD3 and the 4 chains is to mediate activation signals and to regulate the level of TCR expression (16, 38, 57). All of the TCR chains are type I integral membrane proteins (12, 30, 50) . Except for 4 the TCR chains belong to the immunoglobulin (Ig) superfamily (10, 22, 35, 60) .
Tiot[3 heterodimer and the associated CD378E and ge chains. The structural relationships between the subunits of the TCR complex are still not fully known. In this study we examined the role of the extracellular (EC), transmembrane (TM), and cytoplasmic (CY) domain of CD37 in assembly and cell surface expression of the complete TCR in human T cells. A computer model indicated that the EC domain of CD37 folds as an Ig domain. Based on this model and on alignment studies, two potential interaction sites were predicted in the EC domain of CD3~/. Site-directed mutagenesis demonstrated that these sites play a crucial role in TCR assembly probably by binding to CD3e. Mutagenesis of N-linked glycosylation sites showed that glycosylation of CD3~ is not required for TCR assembly and expression. In contrast, treatment of T cells with tunicamycin suggested that N-linked glycosylation of CD38 is required for TCR assembly. Site-directed mutagenesis of the acidic amino acid in the TM domain of CD3~/demonstrated that this residue is involved in TCR assembly probably by binding to Ti13. Deletion of the entire CY domain of CD3~/did not prevent assembly and expression of the TCR. In conclusion, this study demonstrated that specific TCR interaction sites exist in both the EC and TM domain of CD3% Furthermore, the study indicated that, in contrast to CD3q¢, glycosylation of CD38 is required for TCR assembly and expression. T HE T cell receptor (TCR) 1 consists of the disulfide linked Tiot13 heterodimer and the non-covalently associated CD3~/8~ and 42 chains. The function of the Tia13 dimer is to recognize antigen presented on major histocompatibility complex encoded class I or class II molecules on the surface of antigen presenting cells (15, 49) , whereas the major role of the CD3 and the 4 chains is to mediate activation signals and to regulate the level of TCR expression (16, 38, 57) . All of the TCR chains are type I integral membrane proteins (12, 30, 50) . Except for 4 the TCR chains belong to the immunoglobulin (Ig) superfamily (10, 22, 35, 60) .
All the TCR chains are required for efficient TCR expression at the cell surface (8) , but despite extensive research the subunit interactions within the TCR are still not fully understood. Several studies have described the presence of intracellular CD38e, ~/e, 44, and Tiot13 dimers (2, 4, 43) and these dimers can form independently of other TCR chains. Transfection of TCR chains into COS cells has demonstrated a preferential binding of Tia to CD38e
1. Abbreviations used in this paper: C, extracellular constant; CY, cytoplasmic; EC, extracellular; PA, protein A-Sepharose; PCR, polymerase chain reaction; PE, phycoerythrin; TCR, T cell receptor; TM, transmembrane. dimers (2) and cross-linking experiments have shown that Ti[3 is in close contact to CD3~ and to a lesser extent to CD3e at the surface of T cells (6, 31, 52) . From these resuits a TCR model has been proposed in which CD38~ dimers associate with Tic~ and CD3~ dimers associate with Ti13 (41) . It is presently thought that 42 associates with this putative hexameric partial TCR complex via a compound determinant created by the complex. The specific chains that interact with 42 are not known although experiments have indicated that Tia and 13 are involved (20, 21) .
Recent experiments have indicated that the extracellular (EC) domains of the TCR chains are involved in assembly of the TCR. One study demonstrated that the association of CD3 chains with Ti13 was stabilized by the EC constant (C) domain of the Ti13 chain (59) . In another experiment it was shown that the assembly of Tia and Ti13 was dependent on the EC domains of these chains (41) . Both experiments involved the use of COS cells. As different conditions for TCR assembly might exist in non-T cells compared with T cells, conclusions on TCR assembly based on results obtained with non-T cells should be drawn with caution. We have recently demonstrated that the EC domain of CD38 can not substitute for the EC domain of CD3-y in assembly of the complete TCR in T cells (58) . This indicates that the EC domain of CD3~/has a specific role in TCR assembly and expression.
The CD3"y chain contains two N-linked glycosylation sites in the EC domain. The general role of protein glycosylation is still not fully understood. However, experiments have shown that glycosylation might be involved in stabilizing the structure of proteins, in modifying the functional activity of proteins, in recognition events, and in signal transduction after ligand-receptor binding (reviewed in reference 53). In addition, it has recently been demonstrated that mutation of a glycosylation site in the transferrin receptor has a profound negative effect on the appearance of the receptor on the cell surface (61) . The role of CD3~/ glycosylation in assembly, intracellular transport and expression of the TCR is unknown.
Each of the TCR chains contains one or two charged amino acids in their transmembrane (TM) domain. Several studies have demonstrated a requirement of these charged amino acids for complete TCR assembly. Mutation of both the TM basic amino acids in Tict abolished TCR expression in T cells (3, 26) . Furthermore, in COS cells the association of Tit~ with CD3~ was impaired if both the TM basic amino acids in TioL were changed to Leu or if the TM acidic amino acid in CD3~ was changed to Leu (42) . Point mutation of the Til~ TM basic amino acid also abolished TCR expression in T cells due to the inability of the mutated Til3 chain to associate with the CD3 chains (1) . In agreement with this, it has been shown in COS cells that if the charged amino acid in the TM domain of any of the CD3 chains was changed to a hydrophobic amino acid the association between CD3 and the Ti chains was abolished, whereas the CD3-CD3 associations were not dependent on the presence of these charged amino acids (23) . These experiments indicate that the charged TM amino acids of the TCR subunits play an import role in the interaction between Ti and CD3 chains. However, the role of the charged amino acid in the TM domain of CD37 in assembly of the complete TCR has not been studied in T cells. Furthermore, the role of the cytoplasmic tail of CD3~ in TCR assembly and surface expression is unknown.
On the basis of a computer model and alignment studies we identified sites in the EC domain of CD3~/that could be involved in interactions with other TCR chains. The role of these sites in TCR assembly was subsequently analyzed by transfecting site-directed mutagenized CD3~/ cDNA into the CD3~/ negative T cell variant JGN (18) . Furthermore, the role of N-linked glycosylation of the EC domain, the role of the charged residue in the TM domain, and the role of the cytoplasmic (CY) domain of CD3~ for TCR assembly and expression was studied.
Materials and Methods

Computer Model Building
The model of CD3~, was built using software programs from Biosym Technologies (San Diego, CA). The initial model was built using Homology ® and three structures (44, 48, 55) all containing the Ig superfamily fold. The resulting structure was energy minimized using the Discover ® program and the CFF91 forcefield and molecular dynamics were subsequently performed. The final structure was analyzed using program PROCHECK (37) , and the secondary structural elements were identified based on the Kabsh-Sander algorithm (27) .
Cells and Medium
JGN cells, a TCR cell surface negative variant of the human T cell line Jurkat that synthesize no CD3~ (18) , and the original Jurkat cell line, J76, were cultured in RPMI 1640 medium (GIBCO BRL, Paisley, UK) supplemented with penicillin, 0.5 IU/I (Leo, Ballerup, Denmark), streptomycin, 500 mg/1 (Novo, Bagsvoerd, Denmark), and 10% (vol/vol) FCS (Sera-Lab Ltd., Sussex, UK) at 37°C in 5% COz. The Ti[~ deficient Jurkat variant JBN (49) was kindly provided by Dr. R. N. Germain (Bethesda, MD).
Antibodies and Chemicals
The UCHT1 mouse mAb directed against human CD3e was obtained purified and phycoerythrin (PE) conjugated from Dakopatts A/S (Glostrup, Denmark). F101.01 mouse mAb against a conformational epitope on CD3-/~ and CD38e dimers in association with the Ti chains was produced in our own laboratory (19) . HMT-3.2 hamster mAb against an epitope on the IC domain of human CD3"y and mouse CD3~, and ~ was kindly donated by Dr. Ralph Kubo (Cytel Corporation, San Diego, CA).
Constructs and Generation of Stably Transfected Cells
All mutations and truncations were constructed as previously described (16, 18, 57) by the polymerase chain reaction (PCR) using Vent DNA polymerase containing 3'-->5' proofreading exonuclease activity (New England Biolabs, Inc., Beverly, MA) and the wild-type human CD3-/cDNA containing ptasmid pJ6T3~/-2 (33) as template. PCR products were cut with XbaI-Ncol, cloned into the 4.1-kb XbaI-NcoI fragment of pBluescript-13WT (18) and confirmed by complete DNA sequencing. The 1.8-kb XbaI-BamH! pBluescript fragment containing the PCR product was subsequently cloned into the 5.9-kb XbaI-BamHI fragment of the expression vector pTI3Fneo (45) . Transfections were performed using the Bio-Rad Gene Pulser at a setting of 270 V and 960/~F with 40 l~g of plasmid per 2 x 107 cells. After electroporation, cells were maintained in RPMI medium for 24 h and plated at 1 x 104 and 5 × 104 cells/ml in 96-well tissue culture plates (Greiner GmbH, Frickenhausen, Germany) in medium containing 1 mg/ml G418 sulphate (Geneticin) (GIBCO BRL). After 3-4 wk of selection, G418 resistant clones were expanded and maintained in medium without G418.
Flow Cytometric Analysis
Cells were washed twice in ice cold PBS, 0.02% wt/vol NAN3, 1% vol/vol FCS, incubated with PE conjugated mAb for 25 min at 4°C, and washed twice in ice cold PBS. Flow cytometric analysis was performed on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA). Live ceils were gated using forward and side scatter and 10,000 cells were analyzed in each sample.
Biosynthetic Labeling, Solubilization, Immunoprecipitation, and Electrophoresis
For metabolic labeling studies, cells were washed twice in PBS and resuspended at 5 x 106 cells/ml RPMI 1640 without methionine at 37°C for 30 min. After starvation, cells were washed once, resuspended at 5 x 107 cells/ml RPMI 1640 without methionine, and incubated for the period indicated with 500 t~Ci/ml [35S]methionine (Amersham Laboratories, Amersham, UK). In pulse-chase experiments cells were pulsed for 30 min at 37°C and chased in complete medium for the indicated periods. Cells were washed three times in cold PBS, and solubilized for 30 min at 4°C in lysis buffer (20 mM Tris-HCl, pH 8.0, 1 mM MgCl2, 150 mM NaCl, 1 mM PMSF, 8 mM iodoacetamide, and 1% digitonin (Sigma Chemical Co., St. Louis, MO). The supernatant obtained after centrifugation for 5 min at 1500 g was precleared by incubation with protein A-Sepharose (PA) (Pharmacia LKB Biotechnology, Uppsala, Sweden). For immunoprecipitation, precleared lysate was incubated with 1.0 I-~g of mAb for 2 h at 4°C. PA was added and the incubation continued for 2 h. The immunoprecipitates were washed five times in lysis buffer, boiled for 5 min with sample buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.01% bromophenol), and subjected to SDS-PAGE on 12% acrylamide gels. Autoradiography of dried gels was performed by using Hyperfilm-MP (Amersham). 14C-labeled proteins from Amersham were used as molecular mass markers.
Cell Surface Iodination
Cells were surface iodinated as previously described (19) and soluhilized for 45 min at 4°C in lysis buffer. Immunoprecipitation, electrophoresis, and autoradiography were performed as described above.
Deglycosylation Procedures
For deglycosylation studies, cells were surface iodinated, solubilized, and immunoprecipitated as described. The immunoprecipitates were boiled for 5 min in elution buffer (0.5% SDS, 20 mM Tris-HC1, pH 8.0). The eluate was divided in two parts and treated with either 10 U/ml of N-glycanase (Genzyme, Cambridge, MA) or left untreated. After incubation for 18 h at 37°C the eluates were boiled for 5 min in 2× sample buffer and subjected to SDS-PAGE on 12% acrylamide gels.
Tunicamycin Treatment
Cells were biosynthetically labeled as described above in the presence or absence of 1 p~g/ml tunicamycin (Boehringer Mannheim, Vedboek, Denmark).
Results
Prediction of Potential Interaction Sites in the Extracelluiar Domain of CD3 y from a Computer Model
The EC domain of CD3~/has been suggested to fold as an Ig domain since the residues that are considered to be a hallmark of Ig related sequences are present in the CD3~/ EC domain (35, 60) . The strategy used to identify potential interaction sites in the EC domain of CD37 was to search for conserved CD37-specific regions that were not shared with other members of the Ig superfamily since a potential interaction site should not include structurally important amino acids. By alignment of CD37 from human, mouse, rat, and sheep two conserved regions namely amino acid 17-21 and 57-60 were identified (Fig. 1 A) and (39) . The 17-21 and 57-60 regions are not generally shared between CD3~/and other members of the Ig supeffamily except CD3~ in which the 57-60 site, in particular, shows a high degree of conservation ( Fig. 1 A and reference 35, 60) . The 57-60 region was conserved even in the avian CD3 Tl1.15 chain except from a Lys to Asp substitution at position 57 ( Fig. 1 A) . The mere conservation of these CD3"~(~) regions between species suggests that they serve an important functional or structural role. However, since these regions are not conserved among other members of the Ig superfamily it is unlikely that they serve a structural role e.g., in stabilizing the native conformation of the assumed EC Ig domain of CD3~/. To examine whether the 17-21 and 57-60 regions could constitute possible interaction sites a computer model of the EC domain of CD3~t was built. According to the computer model, the EC domain of CD3-y folds as an Ig C domain. A secondary structure prediction according to the Kabcsh-Sander algorithm (27) , based on the 4, and + angles and hydrogen bonding pattern of the residues in the computer model, confirms two anti-parallel [~-sheets characteristic of an Ig C domain. One 13-sheet contains three anti-parallel 13-strands (C, F, and G) whereas the other contains four such strands (A, B, E, and D) (Fig. 2 A) . Ig domain, impose restrictions upon the qb and ~ angles of its residues (54) unless the residue is a Gly that is less restricted. A Ramachandran plot of the computer model ( Fig. 1 B) showed that the residues, which according to the model were part of the B-strands, did in fact exhibit qb and angles that were within the restricted anti-parallel B-strand area. The Gly residues were omitted in this plot.
According to the secondary structure prediction based on the Kabcsh-Sander algorithm (27) the 17-21 region and the majority of the 57-60 region was found in loops (Figs. 1 A and 2). Since loops only have a minor role in maintaining the structure of a protein, this supported the idea that the 17-21 and 57-60 regions did not serve as structurally important regions but could function as interaction sites. Protein-protein interactions usually involve hydrophobic or hydrophilic contacts (25) . In a Kyte-Doolittle plot (36) the 17-21 region was found to include part of the most hydrophobic region of the EC domain of CD3",/as well as a hydrophilic region (Fig. 1 C) . In the computer model the hydrophobic part of the 17-21 region was found to contain two exposed hydrophobic residues (Val 20 and Leu 21). Glu 16 is conserved among human and sheep CD3~/and is exposed according to the computer model. We therefore included Glu 16 in the hydrophilic part of the first conserved region and selected the 16-21 region as a potential interaction site. This region was hereafter denoted the 17 site (Fig. 3) .
The 57-60 region was in a Kyte-Doolittle plot ( Fig. 1 C) found to constitute one of the most hydrophilic regions of the EC domain of CD3"v. This region contains three charged residues (Fig. 1 A) . These charged amino acids could be involved in salt bridges between CD3~ and another protein of the TCR. Alternatively they could merely interact with water or be involved in intra-molecular salt bridges. However, since neither of these interactions are major contributors to the stability of a protein (17) JGNy-WT ~SQEDGSVLL22 JGNy-17
~S-GGGGGG-22
JGNy-WT SSNAKDPRG 6~ JGNy-56
JGNy-Qll7 Figure 3 . Overview of the transfectants.
Truncation of the cytoplasmic tail would probably not explain the conservation of these residues among CD3~/chains from several species. The computer model showed that two of these charged residues were exposed (Asp 58 and Arg 60) (Fig. 2) . Since Ala 56 is conserved among human, mouse, and rat CD3~/and was exposed according to the computer model, the 56-60 region was selected as another potential interaction site. Hereafter this region was denoted the 56 site (Fig. 3) .
Role of the 17 and 56 Sites in TCR Assembly and Expression
The production of the CD3~/negative T cell variant JGN (18) allowed us to study the consequences of various mutated CD3~/chains in TCR assembly and expression. JGN cells do not express the TCR at the cell surface but upon transfection of cDNA encoding wild-type CD3~/into JGN cells they become TCR cell surface positive (Fig. 4 A) . To examine whether the 17 and 56 sites constituted interaction sites, the amino acids 16-21 and 56-60 were replaced with Gly by site-directed mutagenesis in two separate constructs, CD3~/-17 and 56 ( Fig. 3) . Gly was selected because it is expected to adopt the conformation required for the stability of the secondary structure due to its flexibility with respect to the + and ~J angles (54) . Therefore, Gly should not add any strain on the structure. constituted loops and loops seem to prefer Gly due to the conformational requirements of the amino acids in a loop region (11) . In addition, with respect to the functional consequence of the substitution, we expected that Gly would only make a minor contribution to an interaction, whether this was hydrophilic or hydrophobic, due to its lack of side chain. The CD3~-WT, -17, and -56 constructs were separately transfected into JGN cells. Stable clones were selected in medium containing G418 and 30 clones from each of the transfection experiments were subsequently screened for TCR surface expression by FACS analysis. 23 of the JGN'y-WT clones expressed the TCR at the cell surface whereas none of the JGN'y-17 or JGN-y-56 clones expressed the TCR (Fig. 4, A-C) . To analyze whether CD3~/ was synthesized in the transfectants, JGN, JGN',/-WT, JGN'y-17, and JGN',/-56 cells were metabolically labeled, solubilized in lysis buffer containing 1% digitonin, and immunoprecipitated with anti-CD3% anti-CD3e, or F101.01 mAb that only recognizes CD3~/~ or CD3g~ dimers in association with the Ti chains (19) . All of the transfectants synthesized a protein at the size of the CD3"y chain (Fig. 5,   lanes 1, 4, 10, and 13) demonstrating that the lack of TCR cell surface expression in JGN~/-17 and JGN~/-56 cells was not due to a lack of the CD3~ chain. In JGN~/-WT cells the anti-CD3~ mAb clearly coprecipitated CD33, in contrast to JGN'v-17 and JGN~-56 cells in which CD3-/did not coprecipitate with CD3e (Fig. 5, lanes 2, 5, 11, and 14) . Immunoprecipitation with F101.01 demonstrated that both CD3",/E and CD3ge dimers associated with the Tial3 chains in JGN',/-WT cells (Fig. 5, lanes 3 and 12) . In contrast, only CD3ge dimers were found associated with the Tia [3 chains in JGN',/-17 and JGN-/-56 cells (Fig. 5, lanes 6 and 15) .
These results demonstrated that mutation of the 17 and 56 sites had a pronounced effect on TCR assembly and expression. The formation of CD3"ye dimers was markedly decreased in JGN~/-17 and -56 cells as compared with JGN~,-WT and the association between CD3~/and the Tial3 dimer seemed to be reduced, especially in JGN~/-56 cells. The band with a molecular mass of ~27 kD that was precipitated with the anti-CD3-/mAb (Figs. 5 and 9) was also seen in the CD3~/negative cell line, JGN, (Fig. 5, lane 7) and was therefore regarded as a protein unrelated to the TCR components.
Role of N-linked Glycosylation in TCR Assembly and Expression
The role of N-linked glycosylation of the TCR chains is unknown. The EC domain of CD3~ contains two sites for N-linked glycosylation, Asn 30 (N30) and Asn 70 (N70) (Fig. 1 A) . To examine the role of CD3~/glycosylation in TCR assembly and expression three different CD3~ constructs were made by site-directed mutagenesis. In CD3~/-N30Q Gin substituted for Asn 30, in CD3",/-N70Q Gln substituted for Asn 70, and in CD3~-N30/70Q Gin substituted for both Asn 30 and 70 (Fig. 3) . Gln was selected to substitute for Asn because Gln both physically and chemically is similar to Asn and Gln is often seen exchanged with Asn in homologous proteins (14) . Therefore, the consequences of the mutations should only be due to the lack of glycosylation. The constructs were separately transfected into JGN cells. Stable clones were selected in medium containing G418 and several clones from each transfection experi- ment were subsequently screened for TCR surface expression by FACS analysis. As demonstrated in Fig. 4 , D-F all of the constructs allowed TCR cell surface expression. To verify that the transfectants did express the TCR containing the mutated CD3~/ chains at the cell surface, J76, JGN~/-N30Q, JGN~/-N70Q, and JGN~/-N30/70Q cells were surface iodinated, solubilized in lysis buffer containing 1% digitonin, and immunoprecipitated with anti-CD3e mAb. The immunoprecipitates were either treated with N-glycanase or left untreated. J76 cells expressed the fully glycosylated wild-type CD3",/ with a relative molecular mass of 25-28 kD before treatment with N-glycanase and a relative molecular mass of 18 kD after N-glycanase treatment (Fig. 6, lanes 1 and 6) . Interestingly, JGN~-N30Q cells expressed two forms of CD3-¢. One was partially glycosylated and had a relative molecular mass of 19-20 kD whereas the other was not glycosylated and had a molecular mass of 18 kD (Fig. 6, lanes 2 and 7) . JGN~/-NTOQ cells only expressed the partially glycosylated form of CD3~ and JGN,/-N30/70Q cells only expressed the nonglycosylated CD3"~ as expected (Fig. 6, lanes 3, 4, 8, and 9) .
To further study the role of N-linked glycosylation in the assembly of the TCR, J76 cells were preincubated with tunicamycin, metabolically labeled in the presence of tunicamycin, solubilized in lysis buffer containing 1% digitonin, and subsequently immunoprecipitated with anti-CD3~ mAb. Fig. 7 demonstrates that non-glycosylated CD3"y and Till3 dimer coprecipitated with CD3e. However, the non-glycosylated CD38 chain did not coprecipitate with the rest of the complex. This indicated that in contrast to CD3% the glycosylation of CD38 (or another protein) is required in the assembly of CD38 and CD3~.
To examine whether glycosylation of CD3-/ influences its stability in the ER, the JBN cell line, that contains all the TCR chains except Ti[3, was transfected with CD3~-N30/70Q and stable clones were selected in medium containing G418. The absence of Ti[3 ensured that the TCR chains would not escape the ER and the presence of CD3~/-WT allowed comparison of the stability of the nonglycosylated, the fully glycosylated, and the partially glycosylated CD3"y chain. JBN-N30/70Q cells were pulse labeled for 30 min and chased for 0, 1, 2, 6, or 20 h before solubilization in digitonin lysis buffer and immunoprecipitation. Even after a 20-h chase period both the fully and non-glycosylated CD3~/chains were seen (Fig. 8) . This indicated that N-linked glycosylation did not influence the stability of the CD3~/. The disappearance of the partially glycosylated CD3~/ chain could indicate an instability of this chain, or could merely be due to complete glycosyla- tion of this chain. The observed decrease in molecular mass of the fully glycosylated CD3~/chain during the chase period is probably due to oligosaccharide modifications in the ER (32) .
Role of the Transmembrane Charged Amino Acid in TCR Assembly and Expression
To examine the role of the charged amino acid Glu (El00) in the TM domain of CD3% three different constructs were made in which Gin, Leu, and Lys substituted for Glu, respectively (Fig. 3) . The constructs were separately transfected into JGN cells. Stable clones were selected in medium containing G418 and 30 clones from each of the transfection experiments were subsequently screened for TCR surface expression by FACS analysis. 21 of the JGN~-E100Q clones expressed the TCR at the cell surface whereas none of the JGN'y-E100L or JGN'y-E100K clones expressed the TCR (Fig. 4, G-/) . To analyze whether a CD3~/chain was synthesized in the transfectants, JGN~/-WT, JGN~/-E100Q, JGN~/-E100L or JGN~/-E100K cells were metabolically labeled, solubilized in lysis buffer conraining 1% digitonin, and immunoprecipitated with anti-CD3% anti-CD3•, or F101.01 mAb. All of the transfecrants synthesized a protein at the size of the wild-type CD3~/ chain, except for JGN~/-E100K cells in which the mobility of the CD3~/-E100K chain seemed to be markedly influenced by the mutation as the mutated CD3~/ chain comigrated with the CD3~ and • band (data not shown). In JGN~/-WT and JGN'y-E100Q cells the anti-CD3~/mAb coprecipitated the Tiotl3 dimer, the single Til3 and a chains, the 42 dimer and the CD3• chain (Fig. 9,  lanes I and 2) . In contrast, in JGN~/-E100L the anti-CD3~/ mAb did not coprecipitate the 42 dimer and the single Til3 and et chains, and only faint bands of Tial3 dimer were seen as compared with JGN-/-WT and JGN-y-E100Q cells. Only the CD3e chain was coprecipitated as strongly with CD3"y in JGN~-E100L cells as in JGN~/-WT and JGN~/-E100Q cells (Fig. 9, lanes 1-3) . The anti-CD3• mAb coprecipitated CD3~/with similar efficiency from all three cell lines (Fig. 9, lanes 4-6) . The F101.01 mAb precipitated both CD3~/• and CD3~• dimers together with the rest of the TCR from JGN~-WT and JGN'y-E100Q cells but did not precipitate CD3~/• dimers from JGN'y-E100L cells (Fig. 9, lanes 7-9) . In contrast to JGN~/-WT and JGN~/-E100Q cells the 42 dimer was not coprecipitated in JGN~/-E100L cells with any of the mAbs tested further supporting the findings that the TCR was not properly assembled in JGN~/-E100L cells. These experiments demonstrated 4, and 7) , JGN~/-E100Q (lanes 2, 5, and 8), and JGN-~-E100L (lanes 3, 6, and 9) cells were metabolically labeled for 90 min, lysed in digitonin lysis buffer, and then immunoprecipitated using either anti-CD3~ (lanes 1-3) , anti-CD3e (lanes 4-6), or F101.01 mAb (lanes 7-9). Samples were analyzed by SDS-PAGE under nonreducing conditions on a 12% polyacrylamide gel. The positions of the TCR chains are indicated (fg, fully glycosylated; pg, partially glycosylated).
that the chemical and physical properties of the TM Glu in CD3"y play an important role in TCR assembly and expression at the cell surface.
Role of the Cytoplasmic Domain in TCR Assembly and Expression
To examine the role of the CY domain of CD3~/in TCR assembly and expression the construct CD3~-Qll7 st°p was made, in which the entire C ¥ tail of CD3~/ was deleted (Fig. 3) . The construct was transfected into JGN cells, stable clones were selected in medium containing G418 and subsequently screened for TCR surface expression by FACS analysis. As demonstrated in Fig. 4 J, truncation of the CY tail of CD3~/did not impair TCR expression. To verify that CD3~/-Qll7 st°p did express the TCR containing the tail-less CD3~/chain at the cell surface, cells were surface iodinated, solubilized in lysis buffer containing 1% digitonin, and then immunoprecipitated with anti-CD3• mAb. The immunoprecipitates were either treated with N-glycanase or left untreated. As demonstrated in Fig. 6 , lanes 5 and 10, JGN~/-Qll7 cells did express the TCR containing the truncated CD3"y chain at the cell surface.
Discussion
The ExtraceUular Domain
Although the majority of studies describing interactions of the TCR subunits have concentrated on the charged amino acids in the TM domains (1, 3, 13, 23, 26, 42 ) a role of the EC C domains of Tic~ and 13 for complete assembly of the TCR in T cells has been described (9, 21) . These studies describe point mutations of conserved amino acids that caused conformational changes of the Ti C domains and abolished correct TCR assembly and expression (9, 21) . Recently, other experiments have also indicated a role for the EC domain of the TCR chains in the assembly of the TCR complex (41, 59) . Cotransfecting pairs of CD3 chains and chimeric Ti[3-IL2 receptor c~ chains into COS cells indicated that the association between CD3~/, 8, or ¢ and Ti[3 was stabilized by the ECC domain of the Ti[3 chain (59) . Another experiment demonstrated that assembly of Ti[3 with Tier or CD3E involved the extracellular domains of these chains (41) . However, it should be noted that these results were obtained by cotransfecting COS cells with different TCR chains and chimeric proteins. These experiments reflect the ability of isolated TCR chains to interact with each other and do not necessarily represent the interactions that take place in the fully assembled TCR in T cells. We have recently demonstrated that the EC domain of CD38 can not substitute for the EC domain of CD3~ in assembly of the complete TCR in T cells (58) . This indicated that the EC domain of CD3~ might have a role in TCR assembly and lead us to search for potential interaction sites in this domain. The search was made according to the following criteria: (a) the site(s) should be conserved among CD3~ chains but not among other members of the Ig superfamily since general conserved residues most probably have a structural role; (b) the site(s) should include a hydrophilic/hydrophobic region since proteinprotein interactions often involve hydrophilic/hydrophobic contacts; (c) the site(s) should contain exposed hydrophilic/hydrophobic residues that could be directly involved in an interaction; and (d) the site(s) should probably be found in loop regions since such regions have a minor structural role but could have an important functional role. Based on alignment studies ( Fig. 1 A and reference  39) , a Kyte-Doolittle plot (Fig. 1 C) and a computer model of the extracellular domain of CD3~ (Fig. 2 ) two sites were found to fulfill these criteria, namely the 17 and 56 site. The present study demonstrated that both sites were required for proper TCR assembly and cell surface expression. The mutagenized CD3~/(CD3"y-17 or -56) associated weakly, if at all, with CD3¢ and binding to the Tia[3 dimer seemed to be reduced. In contrast, the association to the single Ti[3 seemed to be preserved. It is interesting that both the 17 and 56 site mutations seemed to have almost identical effects on TCR assembly. This indicated that both sites could be part of the same binding site to CD3¢. According to the computer model this is plausible as the 17 and 56 sites are in close contact to each other (Fig. 2 B) . A more detailed analysis involving single point mutations is required to precisely define the binding site to CD3~. We can not exclude the possibility that the mutations affected the general conformation of the EC domain of CD3~ that might be supported by the observation that the partially glycosylated form of CD3~/ was not as clearly seen in JGN~/-17 and JGN~/-56 cells as in JGN~/-WT cells. However, we can conclude that the EC domain of CD3",/is involved in TCR assembly. The preserved binding between the mutated CD3~ in JGN'y-17 or -56 cells and the single Ti[3 indicated that pair-wise interactions between CD3~ and Ti[3 is not dependent on the 17 and 56 sites. In contrast, the association of CD3",/with CD3~ seems to require the 17 and 56 sites. Both the 17 and 56 sites are partially conserved between CD3~/ and CD38 chains from human, mouse, rat, and sheep. Therefore, it could be speculated that these sites serve similar functions in CD3-y and CD38. Experiments have shown that CD3~ and CD38~ dimers can be formed independently of other TCR chains (4, 18) and that CD3~/and CD38 compete for the binding to CD3e (18) . This suggests that CD3~/and 8 each contain a binding site to CD3e and furthermore share a binding site on CD3~. The binding site to CD3~ could be the 17 and 56 sites in both CD3-y and CD38.
Oligosaccharides modify the local structure and overall dynamics of the proteins to which they are attached. They may alter the functional activity of a protein, they may be involved in molecular recognition events, and they may be involved in signal transduction (reviewed in reference 53). Recently a role of oligosaccharides in TCR assembly has been described. Persistence of glucose residues on N-linked oligosaccharides disrupted the associations of the chaperone calnexin with both the Tic~ and [3, and furthermore restricted the ability of the Tic~ and [3 to form heterodimers (28) . In this study we demonstrated that N-linked glycosylation of CD3-,/is not required for TCR assembly and expression. By combining the results from the computer model and the alignment of human, mouse, rat, and sheep CD3"y we found that the N-glycosylation sites in all species were located in other regions of CD3~ than the putative interaction sites 17 and 56. Furthermore, the CD3",/N-glycosylation sites were not conserved with respect to their position. This lack of conservation suggested that the N-glycosylation of CD3-,/is not involved in intermolecular interactions between the TCR subunits. In addition, since the non-glycosylated CD3~/chain was able to function in TCR assembly and expression, this indicated that glycosylation did not have a significant influence on the native conformation of CD3~/. The glycosylation of the TCR chains could, apart from TCR assembly (28), be involved in molecular recognition events at the cell surface of T cells and/ or in signal transduction. Another potential role for glycosylation could be in the degradation of TCR chains in the ER (5). However, our experiments indicated that the stability of CD3"y in the ER was not affected by glycosylation.
It is interesting that JGN~-N30Q cells in addition to the partially glycosylated CD3~/also expressed the non-glycosylated CD3"y chain at the cell surface. This suggested that the efficient glycosylation of Ash 70 to some extent is dependent on the glycosylation of Asn 30. The glycosylation of Asn 30 might cause a conformational change, early in the folding process of CD3-,/, which is required for efficient glycosylation of Asn 70. Experiments performed with tunicamycin showed that the non-glycosylated CD38, in contrast to the other TCR chains, was not coprecipitated with CD3e. This indicated a role of CD38 glycosylation in TCR assembly either directly by interacting with other TCR chains or indirectly by influencing the structure of CD3~. Alternatively, an unknown protein involved in CD3~e dimer formation could be affected. The N-linked glycosylation sites of CD3~ are located differently than the glycosylation sites of CD3~/ (Fig. 1 A) . In CD3~ three (mouse and rat) or two (human and sheep) glycosylation sites are found. In contrast to CD3~/these sites show a high degree of conservation. Interestingly, two glycosylation sites are located just carboxy-terminal of the cysteines responsible for the intramolecular disulfide bond between the B-strands B and F. The first site is conserved among all four species whereas the second site is conserved among CD3~ from human, mouse, and rat (Fig. 1 A) . The 13-strands B and F are the most conserved regions in members of the Ig superfamily and it is likely that attachment of oligosaccharide in the center of these strands, next to the most conserved amino acid in all members of the Ig superfamily, may have an important influence on the conformation of CD3~. Further studies are in progress to study the role of N-linked glycosylation in TCR assembly.
The Transmembrane Domain
Cross-binding experiments have demonstrated a close contact between CD3",/and TiB at the T cell surface (6, 31, 52) . Other experiments have indicated that this association could involve the TM charged residues of TiB and CD3~/ since point mutations of these amino acids abrogated TCR expression in T cells (1) and CD3-Ti association in COS cells (23) , respectively. This is in agreement with our results which demonstrated that the TM charged residue of CD3"y is involved in TCR assembly in T cells, probably through a direct interaction, in the form of a salt bridge, with the basic TM residue in TiB. Mutations of Glu 100 in the TM domain of CD3~, demonstrated that Glu or Gln was required for complete assembly and expression of the TCR. If Leu or Lys substituted for Glu 100 the TCR was not expressed at the cell surface. The presence of CD3~ in the anti-CD3~/precipitate and CD33, in the anti-CD3e precipitate demonstrated that CD3~e dimers were formed in JGN-y-E100L cells. However, in these cells the TiB and the TietB bands were markedly decreased in the anti-CD3"y precipitate as compared to JGN-y-WT cells. The lack of CD3~/ in the F101.01 precipitate further showed that CD3~ did not associate with Tic~B in contrast to CD3~/in JGN~/-WT cells. This demonstrated that Glu 100 in the TM domain of CD3~ is not involved in the association with the CD3e chain but is required for the association between CD3~/e dimers and TictB dimers probably through binding to TiB. Changing Glu to Gin did not abolish TCR assembly and expression. Since Gin both chemically and physically resembles Glu this indicated that the common properties of these amino acids in forming hydrogen bonds or salt bridges are directly involved in TCR assembly. Such a hydrogen bond or salt bridge should be abrogated if Glu 100 was changed to a hydrogen donor such as Lys or to a nonpolar amino acid such as Leu. The lack of TCR surface expression in the JGN~-E100K and JGN~/-E100L transfectants supported this hypothesis.
It seems likely that the TM charged amino acids of the TCR subunits have at least two roles: they are involved in TCR assembly in the ER by stabilizing the interaction between the TCR chains and they are involved in regulation of the assembly process by inducing degradation of TCR chains that are in excess or TCR chains which, for some reason, are not able to function properly in the assembly process. The observation that the bands corresponding to partially glycosylated CD33~ and CD3~ were more intense in JGN'v-E100Q cells than in JGN~/-WT cells could suggest that the E100Q mutation had a stabilizing effect on CD3~/.
The presence of nine charged amino acids in the transmembrane region of the TCR complex is puzzling since this gives a net charge of -3 provided that the TCR only contains one TietB dimer. Whether the TCR contains one or two Tic~[3 dimers is not fully known. However, recent experiments have indicated that only one TiaB dimer is included in each TCR (24, 34, 46, 47) . The BCR has a net charge of -4 and the Fc receptors, Fc~/RIIIA and Fc~RI, each have a net charge of -3 (40) . The reason for this lack of equilibration of the TM region of the TCR, BCR, and FcR is not known, but it could be suggested that these receptors are equilibrated by the presence of a yet unknown membrane protein(s). Recently it has been found that the murine BCR (mlgD) is associated with two proteins, BAP29 and BAP31, which could equilibrate the transmembrane region of the BCR complex (29) .
The Cytoplasmic Domain
It has previously been demonstrated that deletion of the CY domain of either CD3e (51), CD3~ (7), or 4(57) does not prevent assembly and cell surface expression of the TCR. In the present paper we showed that the CY domain of CD3-y is not required for TCR assembly and expression. These observations support the hypothesis that whereas the EC and TM domains of the TCR are required for TCR assembly, expression, and recognition, the CY domains are mainly responsible for signal transduction (38, 56, 57) and internalization of the TCR (16).
In conclusion, based on the results from the present studies on TCR assembly in T cells we have demonstrated that (a) the association between CD3~/and CD3~ requires specific interaction sites in the EC domain of CD3~/but is independent of the charged amino acids in the TM domain of CD3% (b) the association between CD3~/and TiB requires the charged amino acid in the TM domain of CD3~ (Glu) or an amino acid with similar chemical and physical properties (Gln), and (c) the association between CD3~, and Tia[3 is influenced by the ability of CD3~/to assemble with Til3 and to a lesser degree with CD3~ indicating a hierarchy in the TCR assembly process. Finally, glycosylation of CD3-y does not seem to influence the stability of CD3~/or the assembly of the TCR.
